Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project.

ABSTRACT:

Background

Menstrual disorders were not reported as a possible secondary effect in any of the clinical trials for the SARS-CoV-2 vaccines.

Aim

To describe the prevalence of perceived premenstrual and menstrual changes after COVID-19 vaccine administration.

Design

Cross-sectional study.

Methods

A total of 14,153 women (mean age 31.5 ± 9.3 years old) who had received the full course of vaccination at least three months earlier were included in this cross-sectional study. Data including the type of vaccine administered, perceived changes in the amount and duration of menstrual bleeding, presence of clots, cycle length, and premenstrual symptoms were collected through a retrospective online survey from June to September 2021.

Results

Of the women who partici

SUBMITTER: Baena-Garcia L 

PROVIDER: S-EPMC9289916 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature